about
Inflammatory cytokines in pulmonary hypertensionThe German adaptation of the Cambridge pulmonary hypertension outcome review (CAMPHOR)Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathwayImpact of acetazolamide and CPAP on cortical activity in obstructive sleep apnea patientsLong-term data from the Swiss pulmonary hypertension registry.Rehabilitation in patients with pulmonary arterial hypertension.Experience with exercise right heart catheterization in the diagnosis of pulmonary hypertension: a retrospective study.Haemosiderin-laden sputum macrophages for diagnosis in pulmonary veno-occlusive disease.Reference values for the 6-minute walk test in healthy children and adolescents in Switzerland.Evidence for an association between tako-tsubo cardiomyopathy and bronchial asthma: retrospective analysis in a primary care hospital.A low resting heart rate at diagnosis predicts favourable long-term outcome in pulmonary arterial and chronic thromboembolic pulmonary hypertension. A prospective observational studyExercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial.Central venous catheter infection with Brevibacterium sp. in an immunocompetent woman: case report and review of the literature.Featured Article: microRNA-125a in pulmonary hypertension: Regulator of a proliferative phenotype of endothelial cells.Patients with Obstructive Sleep Apnea Have Cardiac Repolarization Disturbances when Travelling to Altitude: Randomized, Placebo-Controlled Trial of AcetazolamideBone mineral density and secondary hyperparathyroidism in pulmonary hypertension.Successful pregnancy in pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report.Evaluation of the pharmacoDYNAMIC effects of riociguat in subjects with pulmonary hypertension and heart failure with preserved ejection fraction : Study protocol for a randomized controlled trial.Weaning from intravenous prostanoids and normalization of hemodynamics by long-term imatinib therapy in severe idiopathic pulmonary arterial hypertension.Exacerbation of sleep apnoea by frequent central events in patients with the obstructive sleep apnoea syndrome at altitude: a randomised trial.Effect of breathing oxygen-enriched air on exercise performance in patients with precapillary pulmonary hypertension: randomized, sham-controlled cross-over trial.Effect of acetazolamide and autoCPAP therapy on breathing disturbances among patients with obstructive sleep apnea syndrome who travel to altitude: a randomized controlled trial.Patients with Obstructive Sleep Apnea at Altitude.Sleep at high altitude: guesses and facts.Association between sleep apnoea and pulmonary hypertension in Kyrgyz highlanders.Exercise pulmonary haemodynamics predict outcome in patients with systemic sclerosis.Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum.Multiple peripheral pulmonary artery stenoses in adults: a rare cause of severe pulmonary hypertension necessitating lung transplantation.Pressure-Flow During Exercise Catheterization Predicts Survival in Pulmonary Hypertension.Precapillary Pulmonary Hypertension and Sleep-Disordered Breathing: Is There a Link?Prevalence of Anxiety and Depression in Pulmonary Hypertension and Changes during Therapy.Disease-Targeted Treatment Improves Cognitive Function in Patients with Precapillary Pulmonary Hypertension.The hypoxia-induced microRNA-130a controls pulmonary smooth muscle cell proliferation by directly targeting CDKN1A.Caveolin-1 Expression and Hemodynamics in COPD Patients.Klippel-Trenaunay syndrome with small vessel pulmonary arterial hypertension.Effect of nocturnal oxygen and acetazolamide on exercise performance in patients with pre-capillary pulmonary hypertension and sleep-disturbed breathing: randomized, double-blind, cross-over trial.Tobacco smoke: a risk factor for pulmonary arterial hypertension? A case-control study.Wrist actigraphy predicts outcome in patients with pulmonary hypertension.Congenital hypersensitivity to vitamin K antagonists due to FIX propeptide mutation at locus -10: a (not so) rare cause of bleeding under oral anticoagulant therapy in Switzerland.Bosentan therapy for chronic thromboembolic pulmonary hypertension. A national open label study assessing the effect of Bosentan on haemodynamics, exercise capacity, quality of life, safety and tolerability in patients with chronic thromboembolic pu
P50
Q27007510-68CF271C-D58B-4FE9-9029-F1D5E5137206Q27497418-419C8CA7-0D52-473B-896C-FD64D3EC003BQ28115005-40F40CA7-1709-4DA6-8828-B7F07938D41AQ28542053-E57FD096-4535-4447-99DC-618D2701B29AQ30889497-3243C4EA-1FCF-4D29-AF31-46DEDD940176Q33168872-2F689815-82EC-4E46-B17F-575792390129Q34410414-F2DB278E-7DA0-4294-9C84-1A12325FF56FQ34690772-970AAC6B-58D4-468D-90C0-1D717DD5FE84Q34894066-415F9B5D-6295-4B01-8E57-402DAC889377Q35157760-C409C22A-502D-4816-ABB7-607EF863FDA3Q36376386-79B0A388-60AE-4486-A142-9428095BB5C0Q36407472-E2F222D4-3724-44E5-AAE3-B465B95D3A00Q36480152-FCD54F60-43E3-42DD-9425-FC0E12FFF6C1Q37071321-4E4315AE-558D-4492-B501-0A6852C288D7Q37185023-0FC08C9B-4603-4470-BAD3-12CADF72BCF3Q37198601-109A81EB-2B5C-42E9-8A6E-A72F735FF8CBQ37304328-B7AD3A44-BDBB-412F-830D-9B98E551BBCAQ37510689-97EB2F63-5CC4-43B0-B361-99FB12F50AD5Q37699659-8FAC57F5-9D58-4D9A-8812-771592F3A0DFQ38373928-FD569964-10BF-43F0-B7FA-BB7B913AA62EQ38379154-95214D5E-881D-43C0-BCC5-607B7D7DCE4FQ38459856-C82E54F8-47DB-4815-B2BA-171BDA2432D7Q38479366-81F62B8A-D256-4C09-A764-62A7F8876040Q38558161-990CEF7F-4194-4394-8E72-6DCDC76CC38FQ39070536-96A74980-BEF0-4120-814D-AB45F9E07DF6Q39204945-07D9A618-404D-4969-88E6-94268E9652ADQ39575243-22AFC688-902C-4D7C-8F02-1145F4E28EB3Q39736973-91BD6E8C-3DC8-4D08-93BB-10DF8F544D9FQ39985779-FF1910E5-17C6-44BB-9EBB-8F37B9246676Q40458782-AD65ED80-19CE-4B5F-9F60-0D5BE03D54D8Q40749723-48D62E8A-25D0-4AB1-A0E8-EE9E6CD723DCQ41248574-3315A8E5-32D7-43BA-84CC-0E78AA524B32Q41436435-70072864-6312-46A6-9511-C403BB7EB373Q42626493-C4B8CB57-C3CD-4892-9F76-B697D68640E8Q43058825-EA7FC1C8-4852-4869-8D8A-B03C2384262CQ44652479-33F06268-7B02-4B4A-87C9-C58F978D8D31Q45026430-5E387A01-9362-4E52-A6F5-F306019781D4Q46563713-F3D80C25-74F4-476C-99FA-4A44F20EFE16Q46739250-7B81A855-DEE6-4C07-AAA9-7A6B988840D9Q46909246-CBD06995-F2E8-4534-B895-135D6BB1DA93
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Silvia Ulrich
@ast
Silvia Ulrich
@en
Silvia Ulrich
@es
Silvia Ulrich
@nl
type
label
Silvia Ulrich
@ast
Silvia Ulrich
@en
Silvia Ulrich
@es
Silvia Ulrich
@nl
prefLabel
Silvia Ulrich
@ast
Silvia Ulrich
@en
Silvia Ulrich
@es
Silvia Ulrich
@nl
P106
P21
P31
P496
0000-0002-5250-5022